These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29762764)

  • 1. Insomnia as a path to alcoholism: tolerance development and dose escalation.
    Roehrs T; Roth T
    Sleep; 2018 Aug; 41(8):. PubMed ID: 29762764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol as a hypnotic in insomniacs: self administration and effects on sleep and mood.
    Roehrs T; Papineau K; Rosenthal L; Roth T
    Neuropsychopharmacology; 1999 Mar; 20(3):279-86. PubMed ID: 10063488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study.
    Roehrs TA; Randall S; Harris E; Maan R; Roth T
    Sleep; 2011 Feb; 34(2):207-12. PubMed ID: 21286241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of L-846 in patients with insomnia: evaluation by polysomnography.
    Sakamoto T; Uchimura N; Mukai M; Mizuma H; Shirakawa SI; Nakazawa Y
    Psychiatry Clin Neurosci; 1998 Apr; 52(2):156-7. PubMed ID: 9628124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
    JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypnotic self administration: forced-choice versus single-choice.
    Roehrs T; Pedrosi B; Rosenthal L; Zorick F; Roth T
    Psychopharmacology (Berl); 1997 Sep; 133(2):121-6. PubMed ID: 9342777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperarousal in insomnia and hypnotic dose escalation.
    Roehrs TA; Roth T
    Sleep Med; 2016 Jul; 23():16-20. PubMed ID: 27692272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep laboratory study of lormetazepam in older insomniacs.
    Vogel GW
    Psychopharmacology Suppl; 1984; 1():69-78. PubMed ID: 6147842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia.
    Kohsaka M; Kanemura T; Taniguchi M; Kuwahara H; Mikami A; Kamikawa K; Uno H; Ogawa A; Murasaki M; Sugita Y
    Expert Rev Neurother; 2011 Oct; 11(10):1389-97. PubMed ID: 21955196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-dose, randomized, double-blind, double dummy, placebo and positive-controlled, five-way cross-over study to assess the pharmacodynamic effects of lorediplon in a phase advance model of insomnia in healthy Caucasian adult male subjects.
    Horoszok L; Baleeiro T; D'Aniello F; Gropper S; Santos B; Guglietta A; Roth T
    Hum Psychopharmacol; 2014 May; 29(3):266-73. PubMed ID: 24911577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypnotic effects of low doses of quazepam in older insomniacs.
    Roth TG; Roehrs TA; Koshorek GL; Greenblatt DJ; Rosenthal LD
    J Clin Psychopharmacol; 1997 Oct; 17(5):401-6. PubMed ID: 9315991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N; Nakajima T; Hayash K; Nose I; Hashizume Y; Ohyama T; Habukawa M; Kotorii N; Kuwahara H; Maeda H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):22-9. PubMed ID: 16048734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
    Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
    J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MSLT in primary insomnia: stability and relation to nocturnal sleep.
    Roehrs TA; Randall S; Harris E; Maan R; Roth T
    Sleep; 2011 Dec; 34(12):1647-52. PubMed ID: 22131601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indole-3-pyruvic acid as a possible hypnotic agent in insomniac subjects.
    Silvestri R; Mento G; Raffaele M; De Luca G; Buttini G; Casella C; Tisano A; De Domenico P; Di Rosa AE; Di Perri R
    J Int Med Res; 1991; 19(5):403-9. PubMed ID: 1748233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
    Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
    Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.